CN102786454A - Bis[1-aryl(alkyl) substituted allyl]sulphane compound and synthetic method and application thereof - Google Patents

Bis[1-aryl(alkyl) substituted allyl]sulphane compound and synthetic method and application thereof Download PDF

Info

Publication number
CN102786454A
CN102786454A CN2011101314445A CN201110131444A CN102786454A CN 102786454 A CN102786454 A CN 102786454A CN 2011101314445 A CN2011101314445 A CN 2011101314445A CN 201110131444 A CN201110131444 A CN 201110131444A CN 102786454 A CN102786454 A CN 102786454A
Authority
CN
China
Prior art keywords
alkane
virtue
allyl
compound
sulfane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011101314445A
Other languages
Chinese (zh)
Inventor
赵晓明
郑生财
黄为青
高宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tongji University
Original Assignee
Tongji University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tongji University filed Critical Tongji University
Priority to CN2011101314445A priority Critical patent/CN102786454A/en
Publication of CN102786454A publication Critical patent/CN102786454A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention provides a bis[1-aryl(alkyl) substituted allyl]sulphane compound, a synthetic method and an application thereof; the compound is an optically pure compound with the following structural formula, wherein x is a chiral carbon atom, R1 is any one selected from C1-C16 alkyls, C4-C10 heterocyclic groups containing N, O or sulfur or C4-C10 ceteroary groups containing N, O or sulfur, or an aryl, and the aryl is a phenyl or a naphthyl. Compared with the prior art, the invention has the advantages of mild reaction conditions, simple operations, good reaction yield, and the like.

Description

A kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds and compound method and application
Technical field
The present invention relates to catalyzer, relate in particular to a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds and compound method thereof.
Background technology
The chirality organosulfur compound small molecules catalysis, pharmaceutical chemistry and complete synthesis in bringing into play important effect; The diallyl containing thioether is an important component part in the Bulbus Allii extract; In the last few years, related work had proved that it had the antitumor characteristic of various cancers [a) Wang, H.C.; Yang, J.H.; Hsieh, S.C.; Sheen.L.Y.J.Agric.Food Chem.2010,58,7096.b) Kim, M.J.; Kwak, J.H.; Baeka, S.H.et, al.Journal of Food Science and Nutrition, 2010,15,137.c) .Khan, A.; Shukla, Y.; Kalra, N.et, al.Mol.Med.2007,13,443.d) .Arora, A.; Kalra, N.; Shukla, Y.; Cancer Lett.2006,242,28.e) .Prasad, S.; Kalra, N.; Shukla, Y.Asian J.Androl.2006,8,719.f) .Haber-Mignard, D.; Suschetet, M.; Berges, R.; Astorg, P.; Siess, M.H.Nutr.Cancer.1996,25,61.g) .Wargovich, M.J.; Imada, O.; Stephens, L.C.Cancer Lett.1992,64,39.h) .Wargovich, M.J.; Woods, C.; Eng, V.W.Stephens, L.C.; Gray, K.Cancer Res.1988,48,6872.i) .Sparnins, V.L.; Barany, G.; Watterberg, L.W.Carcinogenesis.1988,9,131.].The known method for preparing the chirality sulfocompound comprises reaction of the asymmetric sulphur-unsaturated ketenes of this sulphur nucleophilic reagent of Micheal addition attack (aldehyde) and transition metal-catalyzed sulphur allylation reaction etc.Asymmetric sulphur-Micheal addition is the comparative maturity of development at present, and the chirality small molecules catalysis inductive method that its structure sulphur chiral centre mainly contains through the chirality prothetic group of chemical dose is induced, directly chiral reagent is participated in reaction and catalytic amount forms [a) K.Tomioka, A.Muraoka; And M.Kanai.J.Org.Chem.1995; 60,6188-6190.b) C.Palomo, M.Oiarbide; F.Dias; A.Ortiz, A.Linden.J.Am.Chem.Soc.2001,123,5602-5603.c) C.Palomo, M.Oiarbide, F.Dias, Lopez, R.; Linden, A.Angew.Chem., Int.Ed.2004,43,3307-3310.d) C.Palomo; M.Oiarbide et a1.J.Am.Chem.Soc.2006,128,15236.e) K.Nishide, M.Ozeki, H.Kunishige; Y.Shigeta, P.K.Patra, Y.Hagimoto, and M.Node.Angew.Chem.Int.Ed.2003; 42,4515-4517.e) M.Ozeki, K.Nishide, F.Teraoka and M.Node.Tetrahedron:Asymmetry.2004; 15,895-907.e) H.Hiemstra and H.Wynberg.J.Am.Chem.Soc.1981,103,417-430.f) P.McDaid; Y.Chen, and L.Deng.Angew.Chem.Int.Ed.2002,41,338-340.g) P.Ricci; A.Carlone, G.Bartoli, M.Bosco, L.Sambri; And P.Melchiorre.Adv.Synth.Catal.2008,350,49-53.h) K.Suzuki, A.Ikegawa; T.Mukaiyama.Bull.Chem.Soc.Jpn.1982,55,3277-3282.i) M.Marigo, T.Schulte; J.Franzen, and K.A. J.Am.Chem.Soc.2005,127,15710-15711.].And form the chirality sulphur compound through allylation reaction with metal catalytic; Because the sulphur nucleophilic reagent has great difficulty to the poisoning effect (metal being precipitated out or forming some non-tool catalytic activity forms makes reaction be difficult to carry out) of metal catalyst on synthetic from solution.In the previous research of this seminar, we have invented metal iridium catalytic is the allyl substitution reaction of nucleophilic reagent with virtue (alkane) basic sodium mercaptides, a) S.Zheng, N.Gao, W.Liu; D.Liu, X.Zhao, T.Cohen.Organic Letters 2010,12; 4454-4457.b) N.Gao, S.Zheng, W.Yang, X.Zhao.Organic Letters 2011; 13,1514-1516. and utilize more cheap inorganic sulphide has more Atom economy in reaction, also have more challenge.But, also do not have relevant report at present.
Summary of the invention
The object of the invention, for a kind of reaction conditions gentleness is provided, easy and simple to handle exactly, two [1-virtue (alkane) basic substituted allyl] sulfane compounds and compound method thereof that the productive rate of reaction is good.
In order to achieve the above object, the present invention has adopted following technical scheme: a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds is characterized in that this compound is the optical pure compound with following structural formula Wherein * is a chiral carbon atom, R 1Be selected from C arbitrarily 1-C 16Alkyl, C 4-C 10Heterocyclic radical that contains N, O or sulphur or C 4-C 10The heteroaryl that contains N, O or sulphur, aryl, said aryl is a phenyl or naphthyl.
The compound method of a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds; It is characterized in that this method is in organic solvent, temperature of reaction is under-20 ℃-30 ℃; With allyl carbonate ester compound and sodium sulphite or sodium sulphite hydrate is raw material, with [Ir (COD) Cl] 2The iridium complex that generates with the part effect is as catalyzer, and reaction made two [fragrant (alkane) the basic substituted allyl of 1-] sulfane compounds in 36-48 hour under the effect of additive;
Reaction equation can be represented with following formula:
Wherein L is a chiral ligand, and Add. is various additive mentioned above and combination, and Sol. is an all kinds of SOLVENTS mentioned above, and LG is a leavings group, is methyl carbonate, ethyl-carbonate or the carbonic acid tert-butyl ester.
Said allyl carbonate ester cpds, sodium sulphite or sodium sulphite hydrate, [Ir (COD) Cl] 2, part, additive mol ratio be 1: 0.5-3: 0.01-0.5: 0.02-0.1: 0.05-5;
The structural formula of said allyl carbonate ester compound is:
Figure BDA0000062554190000032
Wherein: R 1Be selected from C arbitrarily 1-C 16Alkyl, C 4-C 10Heterocyclic radical that contains N, O or sulphur or C 4-C 10The heteroaryl that contains N, O or sulphur, aryl; L is a chiral ligand, and LG is a leavings group, is methyl carbonate, ethyl-carbonate or the carbonic acid tert-butyl ester;
The structural formula of said sodium sulphite or sodium sulphite hydrate is Na 2SxH 2O, wherein x=0 or 9;
Said part is the optically pure part with following structural formula:
Figure BDA0000062554190000033
Wherein: R 2Or R 3Be selected from C arbitrarily 3-C 16Naphthenic base, phenyl, naphthyl, C 1-C 4Substituted phenyl of alkoxyl group or C 1-C 4The substituted naphthyl of alkoxyl group;
Described additive is cesium carbonate, cesium fluoride, cesium chloride, lithium chloride, Silver monobromide or cesium hydroxide.
Said allyl carbonate ester cpds, sodium sulphite or sodium sulphite hydrate, [Ir (COD) Cl] 2, part, additive mol ratio be 1: 3: 0.02: 0.04: 3, said temperature of reaction was 5 ℃-25 ℃, and the reaction times is 36-48 hour.
Described organic solvent is toluene, methylene dichloride or THF.
Gained two [1-virtue (alkane) basic substituted allyl] sulfane compounds separates through the method for recrystallization, thin-layer chromatography, column chromatography or underpressure distillation.As use recrystallization method, the recommendation solvent is a Virahol, recommends solvent to can be Virahol-normal hexane mixed solvent.With the method for thin-layer chromatography, column chromatography, used developping agent is the mixed solvent of non-polar solvent and polar solvent.Recommend solvent to can be sherwood oil-methylene dichloride, petroleum ether-ethyl acetate, mixed solvents such as sherwood oil-ether, its volume ratio can be respectively: non-polar solvent: polar solvent=100-20: 1.For example: petrol ether/ethyl acetate=100-20/1, sherwood oil/methylene dichloride=100-20/1.
The application of a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds; It is characterized in that; The sulfane compounds is used for the midbody of synthetic sulfur-bearing hybrid compounds, and potential chemotherapy and the antineoplastic chemicals of being used for said two [1-virtue (alkane) basic substituted allyls].
The application of a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds is characterized in that, said two [1-virtue (alkane) basic substituted allyl] sulfane compounds is used to prepare the diallyl sulfone compound and closes the ring sulphones that ring forms.
Described ring sulphones is the optical purity
Figure BDA0000062554190000041
with following structure
Compared with prior art; The invention provides a kind of effectively with the chiral iridium complex compound as catalyzer, by the method for sodium sulphite or sodium sulphite hydrate and the high regioselectivity of allyl carbonate ester cpds, high enantioselectivity and high cis-selectivity synthetic two [1-virtue (alkane) basic substituted allyl] sulfane compounds; The method of preparation multiple two [1-virtue (alkane) basic substituted allyl] sulfane compounds is provided.This method is applicable to dissimilar allyl carbonate ester compounds, and reaction conditions is gentle, and is easy and simple to handle.The productive rate that reacts in addition is better (being generally 67%-99%) also, and the regioselectivity height (be generally 81: 19->99: 1), enantioselectivity high (being generally 97%->99%), cis-selectivity is high (to be generally 85: 15-99: 1).Synthetic of the present invention two [1-virtue (alkane) basic substituted allyl] sulfane compounds can also close ring through RCM and obtain encircling sulphones.
Embodiment
To help to understand the present invention through following embodiment, but not limit content of the present invention.
Embodiment 1~14:
The compound method of two [1-virtue (alkane) basic substituted allyl] sulfane compounds, this method is in organic solvent, temperature of reaction is under-20 ℃-30 ℃, is raw material with allyl carbonate ester compound and sodium sulphite or sodium sulphite hydrate, with [Ir (COD) Cl] 2The iridium complex that generates with the part effect is as catalyzer, and reaction made two [fragrant (alkane) the basic substituted allyl of 1-] sulfane compounds in 36-48 hour under the effect of additive; Reaction equation is following:
Figure BDA0000062554190000051
Wherein Additive refers to additive, and Solvent refers to solvent.
Wherein, additive, temperature and the solvent of the catalytic sodium sulphite allyl sulfide of iridium complex etherificate are different among each embodiment, and its reaction result is following:
Figure BDA0000062554190000052
Wherein DCM is a methylene dichloride, and THF is a THF.Toluene is a toluene.
Embodiment 15~19:
Different ligands is the reaction of the catalytic sodium sulphite allyl sulfide of iridium complex etherificate, and wherein the ligand structure formula is following:
Figure BDA0000062554190000061
Figure BDA0000062554190000062
Embodiment 20:
The reaction of the catalytic sodium sulphite allyl sulfide of iridium complex etherificate:
Figure BDA0000062554190000063
In the reaction tubes of an exsiccant argon shield, add successively [Ir (COD) Cl] 2(0.002mmol), chiral ligand (0.004mmol), Tri N-Propyl Amine (0.2mL) and THF (0.5mL), 50 ℃ of reactions 30 minutes down naturally cool under the room temperature rear pump or output pump and drain.In reaction tubes, add sodium sulphite hydrate (0.6mmol), cesium fluoride (0.6mmol), allyl carbonate (0.2mmol), DCM (2mL), stirring at room reaction more successively.After reaction finishes, after the removal of solvent under reduced pressure residue thin-layer chromatography obtain title product (sherwood oil/methylene dichloride=50/1, or petrol ether/ethyl acetate=50: 1, v/v).
The products therefrom i.e. character of this product is following:
P1: two [(R)-and 1-(4-p-methoxy-phenyl) allyl group] sulfane
Colourless liquid, 99% yield,>99%ee, 98/2dr [chiral column Diacel CHIRALPAK AD-H (0.46cm x 25cm); Normal hexane/Virahol=98/2; Flow velocity=0.7mL/min; Detect wavelength=214nm; t R=11.544 (meso), 14.450 (major) min].
[α] D 20=-142.0°(c?0.5,CHCl 3),
1H?NMR(300MHz,CDCl 3)δ=7.24(d,J=8.4Hz,4H),6.84(d,J=8.8Hz,4H),6.04(ddd,J=16.8,10.2,8.7Hz,2H),5.16(ddd,J=10.2,1.5,0.6Hz,2H),5.13(ddd,J=16.8,1.2,0.9Hz,2H)4.27(d,J=8.7Hz,1H),3.77(s,6H),
13C?NMR(75MHz,CDCl 3)δ=158.7,138.2,132.0,128.9,115.5,113.9,55.2,51.7,
HRMS(EI)calcd?for?C 20H 22O 2S(M +):326.1341,Found:326.1345.IR(KBr):v? max(cm -1)=3902,3852,3751,3648,3629,2834,1866,1772,1538,1504,1456,1247,1174,1032,830,419。
P2: two [(R)-and 1-(3-p-methoxy-phenyl) allyl group] sulfane
Figure BDA0000062554190000072
Colourless liquid, 99% yield, 97%ee, 97/3dr [chiral column CHIRALCEL OJ-H (0.46cm x 25cm); Normal hexane/Virahol=80/20; Flow velocity=0.7mL/min; Detect wavelength=214nm; t R=31.400 (major), 34.869 (meso), 56.381 (minor) min].
[α] D 20=-110.0°(c?0.7,CHCl 3),
1H?NMR(300MHz,CDCl 3)δ7.23(t,J=7.8Hz,2H),6.91(d,J=7.8Hz,2H),6.87(s,2H),6.79(d,J=8.1Hz,2H),6.05(ddd,J=17.4,9.6,9.0Hz,2H),5.18(d,J=9.3Hz,2H),5.16(d,J=17.4Hz,2H),4.29(d,J=8.7Hz,2H),3.79(s,6H),
13C?NMR(75MHz,CDCl 3)δ=159.7,141.5,137.9,129.5,120.2,115.9,113.3,112.9,55.1,52.5,
HRMS(EI)calcd?for?C 20H 22O 2S(M +):326.1341,Found:326.1344.IR(KBr):v? max(cm -1)=3851,3749,3645,3000,2967,2833,1595,1485,1264,1149,1047,919,764,693,455。
P3: two [(R)-and 1-p-methylphenyl allyl group] sulfane
Figure BDA0000062554190000081
Colourless liquid, 99% yield,>99%ee, 96/4dr [chiral column CHIRALCEL OJ-H (0.46cm x15cm); Normal hexane/Virahol=97/3; Flow velocity=1.0mL/min; Detect wavelength=214nm; t R=8.245 (major), 12.279 (minor), 14.984 (meso) min].
[α] D 20=-97.8°(c?0.3,CHCl 3),
1H?NMR(300MHz,CDCl 3)δ=7.21(d,J=7.8Hz,4H),7.12(d,J=7.8Hz,4H),6.05(ddd,J=16.8,9.9,8.7Hz,2H),5.15(d,J=9.3Hz,2H),5.13(d,J=17.4Hz,2H),4.28(d,J=8.7Hz,2H),2.32(s,6H),
13C?NMR(75MHz,CDCl 3)δ=138.2,137.0,136.9,129.3,127.8,115.7,52.2,20.9,
HRMS(EI)calcd?for?C 20H 22S(M +):294.1442,Found:294.1444.IR(KBr):v? max(cm -1)=2913,2847,1681,1509,1010,798,506,470。
P4: two [(R)-and 1-phenyl allyl group] sulfane
Figure BDA0000062554190000082
Colourless liquid, 99% yield, 96%ee, 95/5dr [chiral column CHIRALCEL OJ-H (0.46cm x 25cm); Normal hexane/Virahol=90/10; Flow velocity=0.7mL/min; Detect wavelength=214nm; t R=28.335 (meso), 29.566 (minor), 30.970 (major) min].
[α] D 20=-130.4°(c?0.5,CHCl 3),
1H?NMR(300MHz,CDCl 3)δ=7.32-7.23(m,10H),6.07(ddd,J=17.1,9.6Hz,8.7,2H),5.18(d,J=9.6,2H),5.15(d,J=17.1,2H),4.32(d,J=8.4Hz,2H),
13C?NMR(75MHz,CDCl 3)δ=140.1,138.1,128.6,127.9,127.3,115.9,52.4,
HRMS(EI)calcd?for?C 18H 18S(M +):226.1129,Found:226.1128.IR(KBr):v? max(cm -1)=3903,3853,3750,3735,3675,3648,3628,3566,3028,1868,1770,1730,1679,1557,1505,1455,985,914,696,423,
P5: two [(R)-and 1-rubigan allyl group] sulfane
Figure BDA0000062554190000091
Colourless liquid, 80% yield,>99%ee, 96/4dr [chiral column CHIRALPAK AD-H (0.46cm x25cm); Normal hexane/Virahol=98/2; Flow velocity=0.7mL/min; Detect wavelength=214nm; t R=5.382 (meso), 5.662 (major) min].
[α] D 20=-166.8°(c?0.5,CHCl 3),
1H?NMR(300MHz,CDCl 3)δ=7.29(d,J=8.4Hz,4H),7.23(d,J=8.4Hz,4H),6.00(ddd,J=17.1,9.9,8.4Hz,2H),5.20(d,J=10.5Hz,2H),5.14(d,J=17.1Hz,2H),4.26(d,J=8.4Hz,2H),
13C?NMR(75MHz,CDCl 3)δ=138.4,137.3,133.2,129.3,128.8,116.6,51.7,
HRMS(EI)calcdfor?C 18H 16SCl 2(M +):334.0350,Found:334.0349.IR(KBr):v max(cm -1)=3903,3869,3852,3837,3750,3735,3710,3689,3676,3648,3627,3565,3077,1718,1651,1557,1539,1505,1487,1455,1091,1013,920,820。
P6: two [(R)-1-to the bromophenyl allyl group] sulfane
Figure BDA0000062554190000092
Colourless liquid, 72% yield,>99%ee, 97/3dr [chiral column Diacel CHIRALCEL AY-H (0.46cm x 25cm); Normal hexane/Virahol=99.5/0.5; Flow velocity=0.8mL/min; Detect wavelength=214nm; t R=6.285 (meso), 7.103 (major) min].
[α] D 20=-117.6°(c?0.5,CHCl 3),
1H?NMR(300MHz,CDCl 3)δ=7.44(d,J=8.4Hz,4H),7.17(d,J=8.4Hz,4H),5.99(ddd,J=16.8,9.9,8.7Hz,2H),5.20(d,J=9.9Hz,2H),5.13(d,J=16.8Hz,2H),4.24(d,J=8.4Hz,2H),
13C?NMR(75MHz,CDCl 3)δ=138.8,137.3,131.7,129.7,121.2,116.6,51.7,
HRMS(EI)calcd?for?C 18H 16S? 79Br 2(M +):421.9339,Found:421.9348.IR(KBr):v? max(cm -1)=3903,3852,3802,3751,3734,3676,3649,3628,3567,2925,2363,1870,1732,1717.89,1653,1560,1486,1455,1286,1071,1009,919,815,750,517,418。
P7: two [(R)-and 1-(3-trifluoromethyl) allyl group] sulfane
Figure BDA0000062554190000101
Colourless liquid, 67% yield,>99%ee, 96/4dr [chiral column Diacel CHIRALCEL OJ-H (0.46cm x 15cm); Normal hexane/Virahol=99.8/0.2; Flow velocity=1.0mL/min; Detect wavelength=214nm; t R=3.162 (meso), 3.631 (major) min].
[α] D 20=-113.8°(c?0.7,CHCl 3)。
1H?NMR(300MHz,CDCl 3)δ=7.52(m,7.54-7.51,6H),7.49-7.39(m,2H),6.05(ddd,J=17.1,9.9,8.7Hz,2H),5.26(d,J=9.9Hz,2H),5.19(d,J=17.1Hz,2H),4.37(d,J=8.7Hz,2H)。
13C?NMR(75MHz,CDCl 3)δ=140.8,136.9,131.4,131.1(q,J=30.0Hz),129.2,124.8(q,J=3.8Hz),124.4(q,J=3.8Hz),124.0(q,J=270.7Hz),117.2,52.1。
19F?NMR(282MHz,CDCl 3)δ=-62.60(s)。
HRMS(EI)calcd?for?C 20H 16F 6S(M +):402.0877,Found:402.0878.IR(KBr):v? max(cm -1)=3851,3733,3646,1714,1633,1555,1447,1332,1165,1125,1073,924,770,702,418。
P8: two [(R)-and 1-(2-thienyl) allyl group] sulfane
Figure BDA0000062554190000111
Colourless liquid, 99% yield,>99%ee, 99/1dr [chiral column Diacel CHIRALCEL OJ-H (0.46cm x 15cm); Normal hexane/Virahol (0.1% triethylamine)=99/1; Flow velocity=1.0mL/min; Detect wavelength=214nm; t R=13.363 (meso), 14.090 (major), 19.642 (minor) min].
[α] D 20=-63.6°(c?0.5,CHCl 3)。
1H?NMR(300MHz,CDCl 3)δ=7.23(d,J=5.1Hz,2H),7.08-6.89(m,4H),6.06(ddd,J=16.8,9.9,8.7Hz,2H),5.24(d,J=9.0Hz,2H),5.19(d,J=15.9Hz,2H),4.65(d,J=8.7Hz,2H)。
13C?NMR(75MHz,CDCl 3)δ=143.3,137.6,126.7,125.2,124.9,116.6,47.7。
HRMS(EI)calcd?for?C 14H 14S 3(M +):278.0258,Found:278.0260.IR(KBr):v? max(cm -1)=3903,3852,3819,3749,3735,3675,36483628,3566,3080,1869,1716,1653,1635,1558,1541,1506,1232,986,920,853,696。
P9: two [(S)-and penta-1-thiazolinyl-3-] sulfane
Figure BDA0000062554190000112
Colourless liquid; 84% yield; 98%ee; B/l=81/19,85/15dr, 98%ee. instrument: Agilent6890+CTC (automatic sampler) detector: FID chromatographic column: Rtx-13100 (30m*0.25mm*0.25um) temperature: 150 degree constant temperature 10min sample introduction temperature: 250 degree carrier gas: He flow velocity: 1.0mL/min splitting ratio: 100: 1.t R=3.226 (major), 3.415 (minor, 4.103 (meso) min.
[α] D 20=-85.0°(c?0.1,CHCl 3)。
1H?NMR(400MHz,CDCl 3)δ=5.57(dt,J=16.8,10.0Hz,2H),5.05(dd,J=10.0,1.6Hz,2H),4.94(ddd,J=16.8,1.6Hz,0.4Hz?2H),3.08-3.00(m,2H),1.70-1.48(m,4H),0.95(t,J=7.6Hz,6H)。
Embodiment 21:
The conversion of chirality two [1-virtue (alkane) basic substituted allyl] sulfane compounds, equation is following:
Figure BDA0000062554190000121
Connect embodiment 20 operations, behind the reaction 48h, 0 ℃ of following one kettle way adds the adjacent chloroperoxybenzoic acid of 0.8mmol, stirs 2h, adds 10mL 10%Na 2S 2O 4Solution is the cancellation reaction in system, stirs 10 minutes, adds saturated NaHCO again 310mL, 20mL X 3 dichloromethane extractions, column chromatography obtains 6j.
In the reaction tubes (taking back the stream device) of an exsiccant argon shield, add the DCM solution of 6j, add Grubbs I reagent again, reflux state reaction down spends the night.The TLC detection reaction finishes, and chooses dichloromethane solution, and column chromatography obtains 7j.
P10: (S)-3-((S)-3-butene-2-sulfuryl)-1-butylene
Figure BDA0000062554190000122
One kettle way yield (from 3j) 51%, DL/Meso=89/11, b/1=87/13,99%ee. [chiral column Diacel CHIRALCEL IC (0.46cm x 25cm); Normal hexane/Virahol=90/10; Flow velocity=1.0mL/min; Detect wavelength=214nm; t R=29.080 (major), 34.088 (minor) min].
[α] D 20=-118.3°(c?0.1,CHCl 3).
1H?NMR(400MHz,CDCl 3)δ=5.86(ddd,J=17.2,10.4,8.8Hz,2H),5.41(d,J=10.0Hz,2H),5.34(d,J=17.2Hz,2H),3.88(dq,J=8.8,7.2Hz,1H).
P11: (2S, 2S)-2,5-dimethyl--2,5-dihydro-thiophene 1,1-dioxide
86% yield, 94%ee as a colorless thick oil. [chiral column Diacel CHIRALPAK AD-H (0.46cmx25cm); Normal hexane/Virahol=90/10; Flow velocity=1.0mL/min; Detect wavelength=214nm; t R=15.424 (minor), 17.364 (major) min].
[α] D 20=-128.2°(c?0.2,CHCl 3).
1H?NMR(400MHz,CDCl 3)δ=5.95(s,1H),3.73(q,J=6.8Hz,1H),1.44(d,J=7.2Hz,3H)。
Embodiment 22
The compound method of a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds, this method is in toluene, temperature of reaction is under-20 ℃, is raw material with allyl carbonate ester compound and sodium sulphite, with [Ir (COD) Cl] 2The iridium complex that generates with the part effect is as catalyzer, and reaction made two [fragrant (alkane) the basic substituted allyl of 1-] sulfane compounds in 36-48 hour under the effect of cesium carbonate; Said allyl carbonate ester cpds, sodium sulphite, [Ir (COD) Cl] 2, part, cesium carbonate mol ratio be 1: 3: 0.02: 0.04: 3.
Reaction equation can be represented with following formula:
Figure BDA0000062554190000131
Wherein L is a chiral ligand, and Add. is various additive mentioned above and combination, and Sol. is an all kinds of SOLVENTS mentioned above, and LG is a leavings group, is methyl carbonate.
The structural formula of said allyl carbonate ester compound is:
Figure BDA0000062554190000132
Wherein: R 1Be methyl; L is a chiral ligand, and LG is a leavings group, is methyl carbonate;
Said part is the optically pure part with following structural formula:
Figure BDA0000062554190000133
Wherein: R 2Be cyclohexyl, R 3Be cyclohexyl.
Gained two [1-virtue (alkane) basic substituted allyl] sulfane compounds separates through recrystallization method, and solvent adopts Virahol.
The sulfane compounds is used for the midbody of synthetic sulfur-bearing hybrid compounds, and potential chemotherapy and the antineoplastic chemicals of being used for said two [1-virtue (alkane) basic substituted allyls].
Embodiment 23
The compound method of a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds, this method is in methylene dichloride, temperature of reaction is under 30 ℃, with allyl carbonate ester compound and Na 2S9H 2O is a raw material, with [Ir (COD) Cl] 2The iridium complex that generates with the part effect is as catalyzer, and reaction made two [fragrant (alkane) the basic substituted allyl of 1-] sulfane compounds in 48 hours under the effect of cesium chloride; Said allyl carbonate ester cpds, Na 2SH 2O, [Ir (COD) Cl] 2, part, cesium chloride mol ratio be 1: 3: 0.5: 0.1: 5.
Reaction equation can be represented with following formula:
Figure BDA0000062554190000141
Wherein L is a chiral ligand, and Add. is various additive mentioned above and combination, and Sol. is an all kinds of SOLVENTS mentioned above, and LG is a leavings group, is the carbonic acid tert-butyl ester.
The structural formula of said allyl carbonate ester compound is:
Figure BDA0000062554190000142
Wherein: R 1Be methyl; L is a chiral ligand, and LG is a leavings group, is the carbonic acid tert-butyl ester;
Said part is the optically pure part with following structural formula:
Figure BDA0000062554190000143
Wherein: R 2Be the substituted naphthyl of methoxyl group, R 3Be the substituted naphthyl of methoxyl group.
Gained two [1-virtue (alkane) basic substituted allyl] sulfane compounds separates through the method for thin-layer chromatography, column chromatography.Used developping agent is the mixed solvent of non-polar solvent and polar solvent: petroleum ether-ethyl acetate (volume ratio is 20/1).
Said two [1-virtue (alkane) basic substituted allyl] sulfane compounds is used to prepare the diallyl sulfone compound and closes the ring sulphones that ring forms.
Described ring sulphones is the optical purity
Figure BDA0000062554190000144
with following structure
Embodiment 24
The compound method of a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds, this method is in THF, temperature of reaction is under 5 ℃, with allyl carbonate ester compound and Na 2S9H 2O is a raw material, with [Ir (COD) Cl] 2The iridium complex that generates with the part effect is as catalyzer, and reaction made two [fragrant (alkane) the basic substituted allyl of 1-] sulfane compounds in 36 hours under the effect of lithium chloride; Said allyl carbonate ester cpds, Na 2S9H 2O, [Ir (COD) Cl] 2, part, lithium chloride mol ratio be 1: 0.5: 0.01: 0.02: 0.05.
Reaction equation can be represented with following formula:
Figure BDA0000062554190000151
Wherein L is a chiral ligand, and Add. is various additive mentioned above and combination, and Sol. is an all kinds of SOLVENTS mentioned above, and LG is a leavings group, is ethyl-carbonate.
The structural formula of said allyl carbonate ester compound is: Wherein: R 1Be C 10The heteroaryl of sulfur-bearing; L is a chiral ligand, and LG is a leavings group, is ethyl-carbonate;
Said part is the optically pure part with following structural formula:
Figure BDA0000062554190000153
Wherein: R 2Be methylbenzene, R 3Be methylbenzene.
Gained two [1-virtue (alkane) basic substituted allyl] sulfane compounds separates through the method for thin-layer chromatography, column chromatography.Used developping agent is the mixed solvent of non-polar solvent and polar solvent: sherwood oil-methylene dichloride (volume ratio is 100/1).
Embodiment 25
The compound method of a kind of two [1-virtue (alkane) basic substituted allyl] sulfane compounds, this method is in THF, temperature of reaction is under 25 ℃, with allyl carbonate ester compound and Na 2S9H 2O is a raw material, with [Ir (COD) Cl] 2The iridium complex that generates with the part effect is as catalyzer, and reaction made two [fragrant (alkane) the basic substituted allyl of 1-] sulfane compounds in 36 hours under the effect of cesium hydroxide; Said allyl carbonate ester cpds, Na 2S5H 2O, [Ir (COD) Cl] 2, part, cesium hydroxide mol ratio be 1: 1: 0.05: 0.08: 1.
Reaction equation can be represented with following formula:
Figure BDA0000062554190000154
Wherein L is a chiral ligand, and Add. is various additive mentioned above and combination, and Sol. is an all kinds of SOLVENTS mentioned above, and LG is a leavings group, is ethyl-carbonate.
The structural formula of said allyl carbonate ester compound is:
Figure BDA0000062554190000155
Wherein: R 1Be C 10The heterocyclic radical that contains N; L is a chiral ligand, and LG is a leavings group, is ethyl-carbonate;
Said part is the optically pure part with following structural formula:
Figure BDA0000062554190000161
Wherein: R 2Be C 4The substituted naphthyl of alkoxyl group, R 3Be C 4The substituted naphthyl of alkoxyl group.
Gained two [1-virtue (alkane) basic substituted allyl] sulfane compounds separates through the method for thin-layer chromatography, column chromatography.Used developping agent is the mixed solvent of non-polar solvent and polar solvent: sherwood oil-methylene dichloride (volume ratio is 50/1).

Claims (8)

1. two [1-virtue (alkane) basic substituted allyl] sulfane compounds is characterized in that this compound is the optical pure compound with following structural formula
Figure FDA0000062554180000011
Wherein * is a chiral carbon atom, R 1Be selected from C arbitrarily 1-C 16Alkyl, C 4-C 10Heterocyclic radical that contains N, O or sulphur or C 4-C 10The heteroaryl that contains N, O or sulphur, aryl, said aryl is a phenyl or naphthyl.
2. the compound method of one kind as claimed in claim 1 pair [1-virtue (alkane) basic substituted allyl] sulfane compounds; It is characterized in that; This method is in organic solvent; Temperature of reaction is under-20 ℃-30 ℃, is raw material with allyl carbonate ester compound and sodium sulphite or sodium sulphite hydrate, with [Ir (COD) Cl] 2The iridium complex that generates with the part effect is as catalyzer, and reaction made two [fragrant (alkane) the basic substituted allyl of 1-] sulfane compounds in 36-48 hour under the effect of additive;
Said allyl carbonate ester cpds, sodium sulphite or sodium sulphite hydrate, [Ir (COD) Cl] 2, part, additive mol ratio be 1: 0.5-3: 0.01-0.5: 0.02-0.1: 0.05-5;
The structural formula of said allyl carbonate ester compound is:
Figure FDA0000062554180000012
Wherein: R 1Be selected from C arbitrarily 1-C 16Alkyl, C 4-C 10Heterocyclic radical that contains N, O or sulphur or C 4-C 10The heteroaryl that contains N, O or sulphur, aryl; L is a chiral ligand, and LG is a leavings group, is methyl carbonate, ethyl-carbonate or the carbonic acid tert-butyl ester;
The structural formula of said sodium sulphite or sodium sulphite hydrate is Na 2SxH 2O, wherein x=0 or 9;
Said part is the optically pure part with following structural formula:
Figure FDA0000062554180000013
Wherein: R 2Or R 3Be selected from C arbitrarily 3-C 16Naphthenic base, phenyl, naphthyl, C 1-C 4Substituted phenyl of alkoxyl group or C 1-C 4The substituted naphthyl of alkoxyl group;
Described additive is cesium carbonate, cesium fluoride, cesium chloride, lithium chloride, Silver monobromide or cesium hydroxide.
3. the compound method of two [1-virtue (alkane) basic substituted allyl] according to claim 2 sulfane compounds is characterized in that said allyl carbonate ester cpds, sodium sulphite or sodium sulphite hydrate, [Ir (COD) Cl] 2, part, additive mol ratio be 1: 3: 0.02: 0.04: 3, said temperature of reaction was 5 ℃-25 ℃, and the reaction times is 36-48 hour.
4. the compound method of two [1-virtue (alkane) basic substituted allyl] according to claim 2 sulfane compounds is characterized in that described organic solvent is toluene, methylene dichloride or THF.
5. the compound method of two [1-virtue (alkane) basic substituted allyl] according to claim 2 sulfane compounds; It is characterized in that gained two [1-virtue (alkane) basic substituted allyl] sulfane compounds separates through the method for recrystallization, thin-layer chromatography, column chromatography or underpressure distillation.
6. the application of two [1-virtue (alkane) basic substituted allyl] as claimed in claim 1 sulfane compounds; It is characterized in that; The sulfane compounds is used for the midbody of synthetic sulfur-bearing hybrid compounds, and potential chemotherapy and the antineoplastic chemicals of being used for said two [1-virtue (alkane) basic substituted allyls].
7. the application of two [1-virtue (alkane) basic substituted allyl] as claimed in claim 1 sulfane compounds; It is characterized in that, said two [1-virtue (alkane) basic substituted allyl] sulfane compounds is used to prepare the diallyl sulfone compound and closes the ring sulphones that ring forms.
8. the application of two [1-virtue (alkane) basic substituted allyl] according to claim 7 sulfane compounds; It is characterized in that described ring sulphones is the optical purity
Figure FDA0000062554180000021
with following structure
CN2011101314445A 2011-05-20 2011-05-20 Bis[1-aryl(alkyl) substituted allyl]sulphane compound and synthetic method and application thereof Pending CN102786454A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011101314445A CN102786454A (en) 2011-05-20 2011-05-20 Bis[1-aryl(alkyl) substituted allyl]sulphane compound and synthetic method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011101314445A CN102786454A (en) 2011-05-20 2011-05-20 Bis[1-aryl(alkyl) substituted allyl]sulphane compound and synthetic method and application thereof

Publications (1)

Publication Number Publication Date
CN102786454A true CN102786454A (en) 2012-11-21

Family

ID=47152062

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011101314445A Pending CN102786454A (en) 2011-05-20 2011-05-20 Bis[1-aryl(alkyl) substituted allyl]sulphane compound and synthetic method and application thereof

Country Status (1)

Country Link
CN (1) CN102786454A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101085726A (en) * 2007-06-29 2007-12-12 中国科学院上海有机化学研究所 Method for synthesizing 1,3-disubstitute-4-penten-1-one
CN101245046A (en) * 2008-03-05 2008-08-20 中国科学院上海有机化学研究所 Process for synthesizing 3-indole-1-propylene compounds and uses thereof
CN101565393A (en) * 2009-06-02 2009-10-28 中国科学院上海有机化学研究所 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof
CN101591275A (en) * 2009-07-03 2009-12-02 中国科学院上海有机化学研究所 A kind of synthetic 1, the method for 6-enyne compounds

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101085726A (en) * 2007-06-29 2007-12-12 中国科学院上海有机化学研究所 Method for synthesizing 1,3-disubstitute-4-penten-1-one
CN101245046A (en) * 2008-03-05 2008-08-20 中国科学院上海有机化学研究所 Process for synthesizing 3-indole-1-propylene compounds and uses thereof
CN101565393A (en) * 2009-06-02 2009-10-28 中国科学院上海有机化学研究所 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof
CN101591275A (en) * 2009-07-03 2009-12-02 中国科学院上海有机化学研究所 A kind of synthetic 1, the method for 6-enyne compounds

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHENGCAI ZHENG 等: "one pot iridium-catalyzed asymmetrical double allylations of sodium sulfide: a fast and economic way to construct chiral C2-symmetric bis(1-substituted-allyl)sulfane", 《CHEM.COMMUN.》 *
吴钰娟: "铱催化不对称烯丙基取代反应的研究进展", 《有 机 化 学》 *

Similar Documents

Publication Publication Date Title
Wang et al. Iron‐Catalyzed Imidative Kinetic Resolution of Racemic Sulfoxides
Wu et al. Enantioselective ring opening of meso-epoxides with thiols catalyzed by a chiral (salen) Ti (IV) complex
Marqués‐López et al. Enhanced efficiency of thiourea catalysts by external Brønsted acids in the Friedel–Crafts alkylation of indoles
Demir et al. Study of asymmetric aldol and Mannich reactions catalyzed by proline–thiourea host–guest complexes in nonpolar solvents
CN102675168A (en) Alkane chiral allylic thioether compound and preparation method thereof
Espinosa et al. Asymmetric Conjugate Addition of Malonate Esters to α, β‐Unsaturated N‐Sulfonyl Imines: An Expeditious Route to Chiral δ‐Aminoesters and Piperidones
Pichota et al. Preparation and Characterization of New C2‐and C1‐Symmetric Nitrogen, Oxygen, Phosphorous, and Sulfur Derivatives and Analogs of TADDOL. Part I: Compounds Containing One or Two Sulfur‐Containing Substituents and Use in Cu‐Catalyzed Enantioselective Conjugate Additions to Cyclic Enones
CN106866389A (en) A kind of method for preparing chiral propargyl aryl ethers compounds
CN101245046B (en) 3-indole-1-propylene compounds, process for synthesizing 3-indole-1-propylene compounds and uses thereof
CN102167674B (en) 3-aryl (alkyl) sulfur substituted-1-propylene compound and method of synthesizing same
Kaur et al. Pyrrolidine-carbamate based new and efficient chiral organocatalyst for asymmetric Michael addition of ketones to nitroolefins
Tabassum et al. Imidazolinium sulfonate and sulfamate zwitterions as chiral solvating agents for enantiomeric excess calculations
CN113666826A (en) Method for methoxylation of aryl or heteroaryl
CN102786454A (en) Bis[1-aryl(alkyl) substituted allyl]sulphane compound and synthetic method and application thereof
CN103102230B (en) O-aminophenyl chiral diallyl sulfide compound and its preparation method
Gao et al. Enantioselective synthesis of monofluorinated allylic compounds: Pd-catalyzed asymmetric allylations of dimethyl 2-fluoromalonate using new N-sulfinyl-based ligands
Fernández et al. Chiral sulfur derivatives in the allylation of acyl hydrazones: C 2-symmetric bis-sulfinamides as enhanced chiral organic promoters.
Kumar et al. Metal‐Free Ring‐Opening of Epoxides
CN103896816B (en) A kind of chirality allyl sulfhydrate carboxylate and synthetic method thereof
CN106831508B (en) A method of catalysis asymmetric oxidation thioether
Mizota et al. Synthesis of 1, 2-Diamino Acid Derivatives Utilizing Diastereoselective Tandem N-Alkylation/Homo-and Cross-Addition Reaction of α-Aldimino Thioesters
CN112094222B (en) Preparation method of homoallylamine-oxindole compound with optical activity
Lai et al. Advances in Stereoselective Iron (II)‐Catalyzed Synthesis of Sulfilimines with N‐Mesyloxycarbamates
Bandini et al. New adaptive chiral thiophene ligands for copper‐catalyzed asymmetric Henry reaction
CN101835745B (en) Process for production of disulfonic acid compound, asymmetric mannich catalyst, process for production of beta-aminocarbonyl derivative, and novel disulfonate salt

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20121121